Virtual Psychedelic Conference

Day 1

Featured Speakers
11 videos
Video: Intro & Keynote with Robin Carhart-Harris
Video: Regulation & Law
Video: Science (Day 1)
Video: Technology
Video: Ethics
Video: Patient Experience
Video: Venture Capital & Funding
Video: Crossing Over From Cannabis
Video: PTSD
Video: CEOs (Day 1)
Video: Holistic Wellness

Day 2

Featured Speakers
12 videos
Video: Fireside with Dennis McKenna
Video: Science (Day 2)
Video: CEOs (Day 2)
Video: Capital Markets
Video: Beyond Mental Health
Video: Whole Plant vs Synthetics
Video: Ibogaine & Addiction
Video: Going Mainstream
Video: The Mushroom
Video: Communicating Psychedelics
Video: Philanthropy
Video: Closing Keynote from Rick Doblin

Virtual Psychedelic Conference


About this course

In the midst of a global health crisis, Microdose and The Conscious Fund are hosting a worldwide virtual conference for the emerging psychedelic medicine industry, the biggest global event in the space to date. Given the mental health and wellbeing challenges facing the world, the conference is a timely look at the new treatments and therapies which have astonished researchers.

In partnership with The Green Light and The Conscious Fund, a venture capital fund with active investments in the psychedelics industry, this groundbreaking event will bring together CEOs, investors, scientists, researchers, and regulators for an array of panel discussions and collaborative networking.

Psychedelic drugs are showing incredible promise in their ability to treat a vast range of mental health conditions, including addiction, treatment-resistant depression, PTSD, eating disorders, and many more. Forward thinking scientists, a new breed of psychedelic medicine companies and healthcare advocates are learning to harness the power of psychedelics to tackle the worldwide need for mental wellbeing head-on.

Using new virtual conferencing software, attendees will have access to leading psychedelic experts, and discover the latest trends, while building bridges with thought-leaders and exploring unique investment opportunities.

The conference agenda includes a briefing to set the scene on the psychedelics industry, followed by discussions on psychedelic medicine, drug development, regulation, ethics, investment and much more. One to one and group discussions will take place throughout the event.

  • Duration2 days
  • Lectures23
  • Quizzes0


What kind of background knowledge is necessary?

None, other than an interest in psychedelics. This conference was intended to cover a broad overview of the different aspects around the psychedelics industry.

Do I need to watch the videos in a specific order?

It’s not necessary, although we recommend it. The cirriculum can be watched in any particular order, but a few of the later panels do reference points brought up in earlier panels.

Can I get access to a single course?


Do you offer refunds?

We do not offer refunds at this time.

Featured Panelists

The McKenna Academy

A psychedelic luminary, who has founded the McKenna Academy for Natural Philosophy the first psychedelic university in 1500 years, since the Temple of Eleusis was sacked by the Goths in 396 A.D.

Multidisciplinary Association for Psychedelic Studies (MAPS)

Richard “Rick” Doblin is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Centre for Psychedelic Research

Robin is Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine, Imperial College London.

Chapter 5 Foundation

After retiring from professional hockey, Daniel founded Chapter 5 Foundation, a charitable organization that helps athletes transition into life after the game, where he now uses entheogenic plant healing.

Fungi Perfecti, LLC

Field Trip Psychedelics

Co-founder of Field Trip Psychedelics, Ronan is a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and a director for Trait Biosciences Inc.

JLS Fund

A life-long student of Psychedelics exploring the cultural, regulatory, and the venture landscape of the mushrooming industry. He has travelled the globe learning and living with indigenous communities.

Thank You Plant Medicine

Co-founder of the Thank You Plant Medicine global grassroots movement to destigmatize entheogenic plants and psychedelics, uniting people from over 68 countries and 110 global organizations.

Sansero Life Sciences

CEO and Co-founder of Sansero Life Sciences, developing psilocybin-based pharmaceuticals designed to replace current antidepressants and ADHD medications. Formerly held leadership positions in the natural health and OTC pharmaceutical industries.

Dr. Tanja Schomann is the CEO and co-founder of PSYx, the ‘Systemic Psychedelic’. The World’s 1st platform to future-fit leadership, innovation and (global) systems through PsychoActive Technologies.

Listening to Ecstasy

Charley Wininger has been a psychotherapist in private practice since 1989. Licensed as a Psychoanalyst as well as a Mental Health Counselor. He and his wife Shelley have been instrumental in building the NY MAPS community.

Mindset Pharma

Mr. Lanthier is a seasoned technology executive with strong expertise in business building and corporate finance. In the past, he was founder and COO at Mood Media Corporation, and currently a co-founder at Future Fertility.

Valhalla Private Capital

An active Angel investor in the space, he is a Founder of Valhalla Private Capital and as President of Valhalla Angels Kelowna and Co-President of Valhalla Angels Vancouver, Canada.

Universal Ibogaine

CEO of Universal Ibogaine. He is the former Executive Vice President of Mackie Research Capital and a founding member of the Canaccord Genuity Group.


JR Rahn - CEO of MindMed, is a former Silicon Valley tech executive who worked in market expansion and operations at Uber. After leaving Uber, he was backed by the Silicon Valley tech accelerator Y Combinator for his company Upgraded.

Back of the Yard

VP, Capital Markets at KCSA Strategic Communications where he looks after many facets including the IPO market, investor relations, public relations and digital and social media.

Diamond Therapeutics

25 years of experience in the life science sector, spanning from early to late-stage investments. She is currently at TIAP, an early-stage academic incubator in Toronto and CEO of Diamond Therapeutics.


CEO & Founder at Numinus, he is a former Director, VP and Head of Sales at Mackie Research Capital, with 15 years of experience focusing on early-stage companies.


Chief Scientific Officer at ATAI Life Sciences AG. Dr. has over 19 years of professional experience in the pharmaceutical and biotechnology industries.


Founder of Eleusis, oversees the company's corporate and clinical development effort. Prior to founding Eleusis, Shlomi was a Managing Director at Goldman Sachs, and began his corporate career at JP Morgan.

Synthesis Retreat

Co-founded Synthesis in 2017. He is currently the executive director of an international team of 40 individuals who aim to make psychedelic tools accessible in a safe, legal, and modern context.

Redlight Holland

CEO of Red Light Holland which plans to generate revenues by providing recreational grade truffles and potentially EU-GMP medical-grade truffles to the current adult-use market in the Netherlands.


Co-Founder of Gilgamesh, the drug design company with several psychedelic research tracks, he has worked at Pfizer, Perception Neuroscience, Johnson & Johnson and Click Therapeutics.


Founder of Delic Corp., a company focused on “destigmatizing psychedelics for a mainstream audience, producer of the Bulletproof podcast and worked at the High Times.


Serial entrepreneur and former city councillor in Squamish, BC. She is a speaker on cities, health and technology, and has published research funded by the National Institute of General Medical Science.

Managing Partner at KCSA and oversees the firm's public relations practice. He works to implement eminence, thought leadership, and PR programs designed to build businesses and garner fairer valuations.

Alan Aldous Communications

Alex is the Lead Publicist / "Media Maestro" at Alan Aldous a communications agency specializing in emerging cannabis and psychedelics markets public relations.

CFN Media

CEO at CFN Media, the media network for the emerging cannabis and CBD markets. Before launching CFN Media in 2013, Frank spent the previous 15 years disrupting financial media.

Materia Ventures

Currently serves as the co-founder and CEO of Materia Ventures, a European-focused supply and distribution company for medical cannabis and CBD products.

The Hillhurst Group

Former Chief Commercial Officer, Cronos Group Inc. He pharmaceutical executive with a track record of driving business objectives, growth and efficiency, mitigating risk and increasing bottom-line profit.

Ojai Energetics

CEO of Ojai Energetics, a triple bottom line-driven cannabis technology company with a primary focus on the organic and science-driven nutraceutical and medical sectors.

CBD Virtue

Co-Founder of CBD Virtue, and a Founding Partner at TCF VC. He is also the Chairman of The Cannabinoid Trust as well as advisor to Percuro the animal wellness company.

Alan Aldous Communications

A part of the world's first psychedelic PR company has given him insights that have built on his extensive cannabis company experience, helping to bridge the gaps between science, business and the public.

The Psychedelic Gospels

An anthropologist and activist, who for four decades taught a course on “Hallucinogens and Culture” at Florida International University. He is the author of The Psychedelic Gospels.


Co-Founder and Editor-in-Chief of DoubleBlind, the psychedelics media company. Her work has appeared in VICE, Quartz, the Huffington Post, and Rolling Stone, among others.

Guild of Guides

A co-founder of the Psychedelic Society of the Netherlands, an Assistant Facilitator at Synthesis, a co-founder of the Guild of Guides, and a biohacking and health optimization consultant for Embodying the Mind and for the Longevity Center.

Guild of Guides

Holds an MA in Spiritual Care and has years of professional experience working in mental health and addiction care. He is the co-founder of Guild of Guides Netherlands: an organisation that seeks to professionalize psychedelic sitting services.

Cobidol Group

Co-Founder of Cobidol Group and a Founding Partner at TCF VC. Previously held CEO & partner roles in tech venture capital & is a mentor for the U.K's leading social impact charity.

MAPS Canada

Adjunct professor at the University of British Columbia School of Public and Population Health and Chair of the board of MAPS Canada (Multidisciplinary Association for Psychedelic Studies).


Is one of Canada's most well-known and respected advocates for cannabis reform and an end to the global war on drugs. He opened the world's first microdosing mushroom dispensary, selling microdoses by mail-order.

Executive Director of SPORE, a vehicle to create the foundation for equitable psychedelic reform in the United States and globally, starting in Colorado.


His MAPS sponsored solo show, ‘A Good Trip’, earned Shane a large following. He has appeared on Comedy Central, Jimmy Kimmel Live, Showtime, BBC, Epix and has 5 appearances on Conan.


Drug Test

Sarah Rose Siskind is the host of "Drug Test," a monthly live science comedy show about psychedelics that was recently written up in The New Yorker. She's a psychedelic comedian who has performed at functions for MAPS and The Assemblage and other places. As for her day job, she's a comedy writer for a robot named Sophia at Hanson Robotics, an Artificial Intelligence company. She was head writer for StarTalk with Neil deGrasse Tyson on Nat Geo. She also writes written comedy for UCB, Fox, CBS, wrote jokes for the White House Press Correspondents Dinner, and performs all over New York City. She wrote her Harvard thesis on comedy because what says "funny" more than 130 pages of MLA-formatted, academic text that one graduate student called: "humorous."

Third Wave

Paul F. Austin is an entrepreneur, public speaker, and educator, founder of Third Wave and Synthesis, he has been featured in the BBC, Forbes, and Rolling Stone.

Supports wellness companies by working closely with executives of mid-level market companies to make their visions a reality. She also fundraises for Cosmic Sister and MAPS Canada, and is the founder of Psychedelic Salons.

The Afterlife Coach

CEO of The Afterlife Coach, she has worked with Ayahuasca for 14 years, with a decade as a shamanic apprentice. She has trained as a Master Herbalist and works as a Psychedelics and Ayahuasca Coach.

Eversio Wellness

A seasoned public school educator, yogi, and co-founder of Eversio Wellness, a Canadian start-up company passionate about product development focussed on mental health, awakening consciousness, and cognitive enhancement.

Vitality Wellness Center

Owner/Operator of Vitality Wellness Center in Langley B.C., Natural Health Practitioner, Registered Holistic Nutritionist, Certified Microscopist, Iridologist & Sclerologist, Certified in Herbs & Chinese Medicine.

Alphagreen Group Limited

CEO of Alphagreen Group, a data-driven marketplace for wellness products in the UK and Europe. He was as an investor for a large-cap private equity fund and a family office where he ran the venture capital operations.

European Ibogaine Forum

Educated in the pharmaceutical and chemical industry of Basel, he changed his profession and works as a facilitator, organiser and author. He is involved in Ibogaine projects in Europe and helps others to experience the enormous potential of Ibogaine.


One of the founders of Clear Sky Recovery in Cancun. He worked with Dr. Deborah Mash at the University of Miami’s Ibogaine Research Project at the Leonard M. Miller school of medicine from 2000-2008.

Clear Sky Recovery

Universal Ibogaine’s President has the distinction of having treated more patients with ibogaine than any other person in the world. He graduated from Universidad Anahuac.


Winner of the Amsterdam Film Festival’s Van Gogh award for his documentary film “The Reality Of Truth”, he co-founded the “Ketamine Fund” a nonprofit which gives away ketamine treatments to bring down suicide rates.

Alan Aldous Communications

Alana Armstrong is one-fifth of the concoction called Alan Aldous Communications, bringing 11+ years of journalism to its cognitively diverse table. Alana has spent most of the past five years researching and reporting on the cannabis industry.


CEO/Founder of Sensync. He specializes in digital therapeutics, virtual psychedelic experiences, and the impact of synchronized sensory stimulation on the human nervous system.

Rise Wellness Retreat

Founder of Rise Wellness Retreat and currently acts as Chief Communication Officer for SheCann Cannabis, a medical cannabis patient group.

Psilocybin Stories

The creator of Psilocybin Stories, bringing you a range of psychedelic experiences and reflections to spread awareness and education on the benefits and safe use of psychedelics.

Psychedelic Insights

Co-founder & lead facilitator at Psychedelic insights, founder of Safe Spaces Amsterdam, he also ran a private health service (de Oplaadfabriek) based upon more meditation, less medication.

Simba Health, LLC

An integrative family physician, medical writer/editor, and teacher. She was one of North America's first providers to pursue above-board training in MDMA-assisted psychotherapy with (MAPS).

Dr. Bronner's

Mind Medicine Australia

Tania de Jong AM - Executive Director and co-Founder of Mind Medicine Australia, and a trail-blazing soprano, global speaker, award-winning social entrepreneur and philanthropist.

Psychedelic Science Funders Collaborative


Entrepreneur, social enterprise philanthropist and catalyst for change. He currently helps organizations pursuing FDA and European Medical Association clinical trials of psychedelic medicines for mental health issues.


After 8 years of professional hockey, his hard style of play eventually took its toll so integrated different plant medicines in his recovery of post-concussion syndrome, PTSD and substance abuse issues.

Heroic Hearts Project

A pioneer in psychedelic therapies. As Founder and President of the Heroic Hearts Project, he has spearheaded the research and acceptance of ayahuasca therapy programs for military veterans.

Veterans of War

United States Marine and the leading voice supporting guided psychedelic group therapy for veterans. As Founding Director of Veterans of War, Wyly is deeply committed to changing the mental health paradigm regarding trauma, plant medicine, and veteran suicide.

Veterans Ananda

Served 4 yrs & 1 deployment in the U.S. Army, prior to being medically retired for epilepsy from a TBI & PTSD. Sarah's mission is to educate others about post-service issues & eradicate veteran suicide.

Yes On IP 34

Campaign Manager for the Yes On IP 34 Campaign (aka the Psilocybin Services Initiative) in Oregon, to create the first-ever statewide regulated Psilocybin therapy program in the United States.

Darkhei Rephua

Founder of Darkhei Rephua, a nonprofit dedicated to entheogenic plant medicine education and intersectional outreach in New York City and founder of Decriminalize Nature.

Barrister & Solicitor, Lloyd Law Professional Corporation

Toronto cannabis lawyer, editor at Green Candy Press, he works with Tousaw Law Corporation and is a leading psychedelic medicine advocate.

Decriminalize California

Co-founded Monterey County NORML (National Organization for the Reform of Marijuana Laws) in 2013. He set up Decriminalize California to make sure that psychedelic mushroom lovers were properly represented.

Gama Glória

Lawyer, policy advisor, law professor, founding partner of Lisbon based Gama Glória, and a senior advisor of the Albright Stonebridge Group in Washington DC.


An American social and political activist, best known for his efforts to legalize marijuana and to promote the benefits of Ibogaine as an addiction treatment. He is a long-term activist in the Youth International Party (Yippies).

BioReset Medical

Maastricht University

Professor in psychopharmacology at Maastricht University, his works in psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug-induced changes in human performance.

Geneticist and neurophysiologist with extensive global research connections. Background in molecular mechanisms of memory and immunogenetics and anti-ageing research.

Ibogaine Expert

On the board of Universal Ibogaine, which will IPO as Clear Sky Addiction Solutions later this year ahead of phase II ibogaine trials. He served as Executive Director of the Global Ibogaine Therapy Alliance and helped set up Tabula Rasa Retreat in Portugal, a leading ibogaine treatment facility.

Toronto Centre for Psychedelic Science

Cybin Corp's Clinical Advisor, he is the Research Director and Co-founder of the Psychedelic Studies Research Program (PSRP) at the University of Toronto and the Toronto Centre for Psychedelic Science (TCPS).

One of the world's foremost experts on ibogaine. She is the CEO and Founder of DemeRx Inc., a clinical-stage drug development company advancing the treatment of opioid use disorder.

Macquarie University

Senior Research Fellow in the Department of Cognitive Science at Macquarie University in Sydney. His research investigates cognitive and neurological changes in altered states of consciousness.

Clinical Advisor

One of the few sector scientists in India, he has a Masters in Clinical Psychology with a penchant for research in psychedelics and its psychological constructs. He brings many years of experience from the lab and the clinic.

Imperial College of London

A psychologist educated at the Catholic University of Chile with a Masters in Neuroscience and Neuropsychological Therapy from the University of Bologna.

John Hopkins University

PhD - Professor at Johns Hopkins, is an expert on psychedelics, other psychoactive drugs, and addiction. Dr. Johnson has published 119 papers, including 47 manuscripts focused on psychedelics.

Andromeda Entertainment

CEO of Andromeda Entertainment, a game designer and public speaker in consciousness technology. He is the lead developer of SoundSelf: A Technodelic, where technology can profoundly impact player consciousness.

CEO of He is focused on extracting meaningful insights from personal journals and recorded sessions to help improve psychedelic research, therapy, and knowledge mobilization.

Radix Motion

CEO of Radix Motion, focused on increasing wellness and productivity by combining neuroscience and virtual reality with a Masters in Cognitive Neuroscience.

University of Sussex

Professor of Cognitive and Computational Neuroscience at the University of Sussex and Founding Co-Director of the Sackler Centre for Consciousness Science.

Mindleap Health

CEO of Mindleap Health a platform for psychedelic aftercare and new forms of medicine. He led data analytics and cybersecurity projects for Fortune 500 companies, and the US and Canadian Governments.

CAIN / Numinus

Co-founder of Numinus. Her inspiration for founding the company came after a series of near-death experiences related to illness and misdiagnosis.


A psychonautic explorer striving to revolutionize myco-cultivation infrastructure, enabling access for all, to food and medicine for body mind and spirit. He has worked with DARPA's Polymorphic Computing Architecture project.

The Sporing Company

CEO of The Sporing Company, David has a 25-year background in Sales and Marketing with experience in many industries including retail analytics, security, and cannabis.

The Psilocybin Mushroom Bible

Ph.D. in mushroom botany, co-author of The Psilocybin Mushroom Bible, now researching the medicinal qualities of psilocybin. He works as a consultant for commercial mushroom producers around the world.

PLEDG (Psychedelic Liberation, Education, Discipline & Guidance)

Founder at MycoMeditations, the 1st Indiana State Certified Wild Mushroom Expert, a cultivator and founder of the non-profit PLEDG, (Psychedelic Liberation Education Discipline and Guidance).

ATAI Life Sciences

Co-Founder and Chief Executive Officer of ATAI Life Sciences AG, as well as a Seed and Series A investor in COMPASS. His prior experience includes Rocket Internet, Allianz Tanzanian German Program to Support Health.

Tabula Rasa Ventures

Marik is an entrepreneur, engineer, and advocate who has worked across “counter-culture” industries. He founded Iliac which built technology for performer rights in the adult entertainment industry. Later he began working with decentralized governance organizations in the blockchain space. His work focuses on providing more opportunities, resources, infrastructure, and human rights access to communities affected by cultural stigmatization. Marik is a co-founder of Tabula Rasa Ventures - a community-led investment firm focused on financing and supporting a more equitable, diverse, and compassionate psychedelic ecosystem.


International Lawyer, AD LUCEM LAW CORPORATION and serves as a Board Advisor to the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada and Steve DeAngelo’s Last Prisoner Project.

Leafy Tunnel

A founding partner at Leafy Tunnel, an investment firm dedicated to investing in early-stage companies focused on bringing plant-based therapies into mental health and palliative care markets.


Founder and Managing Partner at Arcadian Fund Management and Arcadian Capital Partners, a venture fund focused on the ancillary service providing companies in and around the cannabis and hemp industries.

Decriminalize California

Sansero Life Sciences / Inplanta Biotech

Co-founder of Sansero Life Sciences Inc., a psychedelic pharmaceutical company based in Canada. He has a Ph.D. in molecular biology and genetics specializing in the genetic engineering of crop plants.

Brightminds Bio

CEO of Bright Mind Bioscience, a Canadian biotechnology company developing new psilocybin drugs for mental health treatment. Previously he served on the management team at Avnel Gold.


CEO of Psygen Labs Inc. and former General Manager at Aurora Cannabis after graduating from the University of Victoria with a BSc in Chemistry (honours).

Orthogonal Thinker

COO of Orthogonal Thinker, a multidimensional wellness platform dedicated to individual and collective well-being via psychoactive compounds and clean label products.


In partnership with The Green Light and The Conscious Fund, a venture capital fund with active investments in the psychedelics industry, this groundbreaking event will bring together CEOs, investors, scientists, researchers, and regulators for an array of panel discussions and collaborative networking.

Day 1 0/11

Featured Speakers

Robin Carhatt-Harris, Daniel Carcillo, Jeremy Weate Ph.D., Dr. Erica Zelfand, Robert Laurie, Florian Brand, Luc van Poelje, Ronan Levy, William Hilson, Srinivas Rao MD, Ph.D.

11 videos
Video: Intro & Keynote with Robin Carhart-Harris
64 minutes
Video: Regulation & Law
36 minutes
Video: Science (Day 1)
50 minutes
Video: Technology
49 minutes
Video: Ethics
49 minutes
Video: Patient Experience
50 minutes
Video: Venture Capital & Funding
42 minutes
Video: Crossing Over From Cannabis
43 minutes
Video: PTSD
47 minutes
Video: CEOs (Day 1)
53 minutes
Video: Holistic Wellness
42 minutes

Day 2 0/12

Featured Speakers

Dennis McKenna, Rick Doblin, Paul Stamets, Sarah Rose Siskind, Zappy Zapolin, Shane Mauss, Grant Lawrence, Vince Polito, Deborah Mash Ph.D., David Kurth

12 videos
Video: Fireside with Dennis McKenna
56 minutes
Video: Science (Day 2)
47 minutes
Video: CEOs (Day 2)
42 minutes
Video: Capital Markets
53 minutes
Video: Beyond Mental Health
47 minutes
Video: Whole Plant vs Synthetics
45 minutes
Video: Ibogaine & Addiction
38 minutes
Video: Going Mainstream
43 minutes
Video: The Mushroom
33 minutes
Video: Communicating Psychedelics
49 minutes
Video: Philanthropy
49 minutes
Video: Closing Keynote from Rick Doblin
88 minutes


Our course begins with the first step for generating great user experiences: understanding what people do, think, say, and feel. In this module, you’ll learn how to keep an open mind while learning.

0 Rated 0 out of 0 Ratings

5 stars 0

4 stars 0

3 stars 0

2 stars 0

1 stars 0

User Registration

Reset Password